Davis Polk Advises Solazyme on Its Private Placement of Convertible Preferred Stock
Davis Polk is advising Solazyme, Inc. (SZYM) in connection with its private placement of approximately $28 million of its Series A convertible preferred stock to Glenhill Capital Advisors…